Document is current
Any future updates will be listed below
-
Authors
Juratli, Tareq A. http://orcid.org/0000-0003-2236-6719
Prilop, Insa
Saalfeld, Felix C.
Herold, Sylvia
Meinhardt, Matthias
Wenzel, Carina
Zeugner, Silke
Aust, Daniela E.
Barker, Fred G. 2nd
Cahill, Daniel P.
Brastianos, Priscilla K.
Santagata, Sandro
Schackert, Gabriele
Pinzer, Thomas
- License Information
-
More Information
Article History
Received: 3 December 2020
Accepted: 23 December 2020
First Online: 6 January 2021
Competing interests
: TAJ received honoraria from CSL Behring and Roche Pharma AG unrelated to the submitted work. PKB reports honoraria for consulting from Tesaro, Lilly, Angiochem, and Genentech-Roche; speaker’s honoraria from Genentech-Roche and Merck; and research funding (to Massachusetts General Hospital) from BMS, Pfizer, Lilly and Merck. DPC reports receiving honoraria from Merck, Lilly and Boston Pharmaceuticals outside the submitted work. SS is a consultant for RareCyte. The remaining authors have no competing interests to disclose.
